These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Red flags phenotyping: A systematic review on clinical features in atypical parkinsonian disorders. Bhidayasiri R; Sringean J; Reich SG; Colosimo C Parkinsonism Relat Disord; 2019 Feb; 59():82-92. PubMed ID: 30409560 [TBL] [Abstract][Full Text] [Related]
13. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies. Chalmers KA; Love S J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683 [TBL] [Abstract][Full Text] [Related]
14. Assessing disease progression with MRI in atypical parkinsonian disorders. Köllensperger M; Wenning GK Mov Disord; 2009; 24 Suppl 2():S699-702. PubMed ID: 19877233 [TBL] [Abstract][Full Text] [Related]
15. Degeneration in different parkinsonian syndromes relates to astrocyte type and astrocyte protein expression. Song YJ; Halliday GM; Holton JL; Lashley T; O'Sullivan SS; McCann H; Lees AJ; Ozawa T; Williams DR; Lockhart PJ; Revesz TR J Neuropathol Exp Neurol; 2009 Oct; 68(10):1073-83. PubMed ID: 19918119 [TBL] [Abstract][Full Text] [Related]